Merck Tbk. vs WIR ASIA Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while WIR ASIA Tbk. trades at Rp53 (market cap 632.75B, 74.95M 24h volume). The key difference: Merck Tbk. is far larger — about 2.7× WIR ASIA Tbk.'s market cap, and WIR ASIA Tbk. is more actively traded (74.95M versus 37.6K). Which is the better fit depends on your goals.
| MERK | WIRG | |
|---|---|---|
Market Cap | 1.7T | 632.75B |
Volume | 37.6K | 74.95M |
Lot | 376 | 749.53K |
Turnover | 144.47M | 3.97B |
Average Price | 3,842.23 | 53.02 |
Value | 144.47M | 3.97B |
Indicative Equilibrium Price | 3,840 | 53 |
Indicative Equilibrium Volume | 7 | 23.65K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT WIR ASIA Tbk (the Company) was established on Notarial Deed No. 16 dated August 15, 2011 of Musa Muamarta, S.H. The Company started its commercial operations in 2013.
Read more on WIRG →